PIK3CA and urinary bladder cancer: We will collect the tumor samples from patients with bladder cancer and the relationship between loss of PTEN and the mutation of PIK3CA can be observed by “Next-generation” sequencing technology (NGS) sequencing, laying a foundation for the treatment of bladder cancer.